Lorazepam Has Negative Impact on Survival in Pancreatic Cancer
TUESDAY, Aug. 22, 2023 -- Lorazepam stimulates fibrosis and inflammatory signaling and is associated with reduced survival in patients with pancreatic cancer, according to a study published online Aug. 17 in Clinical Cancer Research.
Abigail C....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Ativan | Cancer | Cancer & Oncology | Lorazepam | Pancreas | Pancreatic Cancer | Pharmaceuticals | Study